UA36252A - Method for assessment of somatic individuality of patient required for selection of adequate therapy - Google Patents

Method for assessment of somatic individuality of patient required for selection of adequate therapy

Info

Publication number
UA36252A
UA36252A UA99116369A UA99116369A UA36252A UA 36252 A UA36252 A UA 36252A UA 99116369 A UA99116369 A UA 99116369A UA 99116369 A UA99116369 A UA 99116369A UA 36252 A UA36252 A UA 36252A
Authority
UA
Ukraine
Prior art keywords
individuality
somatic
assessment
selection
patient required
Prior art date
Application number
UA99116369A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Ірина Михайлівна Ільіна
Ирина Михайловна Ильина
Нонна Олександрівна Кравчун
Нонна Александровна Кравчун
Ольга Аркадіївна Гончарова
Ольга Аркадьевна Гончарова
Original Assignee
Український Науково-Дослідний Інститут Фармакотерапії Ендокринних Захворювань
Украинский научно-исследовательский институт фармакотерапии эндокринных заболеваний
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Український Науково-Дослідний Інститут Фармакотерапії Ендокринних Захворювань, Украинский научно-исследовательский институт фармакотерапии эндокринных заболеваний filed Critical Український Науково-Дослідний Інститут Фармакотерапії Ендокринних Захворювань
Priority to UA99116369A priority Critical patent/UA36252A/en
Publication of UA36252A publication Critical patent/UA36252A/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention relates to the medicine and may be used in therapy. The inventive objective was to improve the efficacy due to the search for the additional objective markers for the assessment of the somatic individuality of the patient required for the selection of the adequate therapy. The method of iridodiagnostics is used for this purpose.
UA99116369A 1999-11-23 1999-11-23 Method for assessment of somatic individuality of patient required for selection of adequate therapy UA36252A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA99116369A UA36252A (en) 1999-11-23 1999-11-23 Method for assessment of somatic individuality of patient required for selection of adequate therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA99116369A UA36252A (en) 1999-11-23 1999-11-23 Method for assessment of somatic individuality of patient required for selection of adequate therapy

Publications (1)

Publication Number Publication Date
UA36252A true UA36252A (en) 2001-04-16

Family

ID=74182299

Family Applications (1)

Application Number Title Priority Date Filing Date
UA99116369A UA36252A (en) 1999-11-23 1999-11-23 Method for assessment of somatic individuality of patient required for selection of adequate therapy

Country Status (1)

Country Link
UA (1) UA36252A (en)

Similar Documents

Publication Publication Date Title
ATE468137T1 (en) INHIBITORS OF HMGB1 FOR THE TREATMENT OF TISSUE DISEASES
DE60037394D1 (en) USE OF p53 INHIBITORS FOR THE TREATMENT OF SIDE EFFECTS IN CANCER THERAPY
NO20004803L (en) Smilagening and anzurogenin for the treatment of Alzheimer's disease
DE60026538D1 (en) PHARMACEUTICAL PREPARATIONS THE CLAVULANIC ACID OR DERIVATIVES CONTAIN FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
ATE350030T1 (en) NORDIHYDROGUAIARETIC ACID DERIVATIVES FOR THE TREATMENT OF TUMORS
EP1767197A3 (en) Treatment of Alzheimer's disease with inhibitors of cell cycle re-entry and progression
DE69722426D1 (en) ISOBUTYLGABA AND ITS DERIVATIVES FOR THE TREATMENT OF PAIN
AU3142597A (en) Dha-pharmaceutical agent conjugates
AU7186501A (en) Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases
HK1051499A1 (en) Method for treating ocular pain
CY1107640T1 (en) METHOD FOR CERTIFICATING FACTORS FOR DIABETES TREATMENT
MY138883A (en) Use of asiatic acid for treatment of cencer
ATE260282T1 (en) AROMATIC ESTERS OF CAMPTOTHECINES AND METHOD FOR THE TREATMENT OF CANCER DISEASES
ATE368455T1 (en) USE OF (+)-TRAMADOL, O-DEMETHYLTRAMADOL, O-DESMETHYL-N-MONO-DESMETHYL-TRAMADOL FOR THE THERAPY OF URINARY INCONTINENCE
HUP0000873A2 (en) The use of levobupivacaine in facial surgery
ATE332688T1 (en) USE OF CARBINOLES FOR THE TREATMENT OF NEUROPATHIC DYSFUNCTION
GB0020504D0 (en) Therapeutic method
PT1152762E (en) USE OF DEOXYGEGANIN IN THE TREATMENT OF ALZHEIMER'S DEMENTIA
MXPA02005069A (en) Tr3 specific binding agents and methods for their use.
AU2001267687A1 (en) Ruthenium (ii) compounds for use in the therapy of cancer
UA36252A (en) Method for assessment of somatic individuality of patient required for selection of adequate therapy
IL139144A0 (en) Mycobacterial inhibitors
AU5434899A (en) Cancer treatment
HUP9903685A2 (en) Use of olanzapine for the preparation of pharmaceutical compositions treating excessive aggression
MXPA02004704A (en) Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders.